Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.
Mol Nutr Food Res. 2014 Jan;58(1):79-86. doi: 10.1002/mnfr.201300528. Epub 2013 Nov 24.
Nutraceuticals, the bioactive food components represented by many naturally occurring dietary compounds, have been investigated for a few decades for their numerous beneficial effects, including their anticancer properties. The initial interest in the cancer-preventing/therapeutic ability of these agents was based on their ability to affect multiple signaling pathways that are deregulated in cancer cells. With a shift in the focus of cancer research to the emerging areas such as epigenetic regulation, microRNAs (miRNAs) and the cancer stem cells (CSCs), nutraceuticals initially appeared out of place. However, research investigations over the last several years have slowly but firmly presented evidence that supports a relevance of these agents in modern day research. While nutraceuticals are increasingly being realized to alter miRNA/CSCs expression and function, the molecular mechanism(s) are not very clearly understood. Epigenetic regulation is one mechanism by which these agents exert their anticancer effects. In this focused mini review, we summarize our current understanding of epigenetic regulation of miRNAs and CSCs by nutraceuticals. We discuss both direct and indirect evidences that support such an activity of these compounds.
营养药物,由许多天然存在的膳食化合物代表的生物活性食品成分,已经被研究了几十年,因为它们有许多有益的作用,包括抗癌特性。最初对这些药物的抗癌/治疗能力的兴趣是基于它们能够影响癌细胞中失调的多种信号通路。随着癌症研究的重点转移到新兴领域,如表观遗传调控、microRNAs(miRNAs)和癌症干细胞(CSCs),营养药物最初似乎并不合适。然而,过去几年的研究调查缓慢但坚定地提供了证据,支持这些药物在现代研究中的相关性。虽然营养药物越来越被认为可以改变 miRNA/CSCs 的表达和功能,但分子机制尚不清楚。表观遗传调控是这些药物发挥抗癌作用的一种机制。在这个重点迷你综述中,我们总结了我们目前对营养药物对 miRNA 和 CSCs 的表观遗传调控的理解。我们讨论了支持这些化合物这种活性的直接和间接证据。